SH CCILC: Chemotherapy after Checkpoint Inhibitors in Lung Cancer Skip To Content

Study ID: SH CCILC: Chemotherapy after Checkpoint Inhibitors in Lung Cancer

Title:

SH CCILC: Chemotherapy after Checkpoint Inhibitors in Lung Cancer

Location:
Sioux Falls Region
Principal Investigator:
Guy Vin Chang, MD
Disease:
Lung
Stage:
Retrospective
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.